NCT07049536

Brief Summary

Hematopoietic stem cell transplantation is a treatment used to restore blood cell function in diseases of myeloid and lymphoid origin, which can be malignant or non-malignant. There are two types: autologous transplantation, which uses the patient's own stem cells, and allogeneic transplantation, which uses stem cells from a donor after a high-dose chemotherapy and radiotherapy preparation. This process can lead to complications such as immune reactions, infections, and organ toxicity, affecting the cardiovascular, musculoskeletal, and nervous systems. These complications often reduce physical activity, muscle strength, lung function, and quality of life. Before transplantation, it is important to assess patients' comorbidities, functional status, and physical fitness to evaluate their ability to tolerate treatment and risk of complications. Low exercise tolerance and impaired physical function are linked to poorer outcomes. Objective tests of physical function provide valuable information about health status. Pre-transplant muscle strength and cardiopulmonary fitness influence post-transplant recovery, so comprehensive assessments are necessary. Physiotherapy and rehabilitation support patients by preparing them for treatment, maintaining health during therapy, improving physical function after treatment, and enhancing quality of life in palliative care. Exercise improves functional capacity, quality of life, and daily activities, but symptoms like fatigue, pain, breathlessness, and muscle weakness, as well as other barriers, may limit participation. Physical fitness is the body's ability to perform daily activities efficiently. Reduced fitness leads to frailty and decreased function, which are associated with increased treatment toxicity and mortality. Although the importance of physical fitness before transplantation is recognized, data from objective measurements are limited. Common pre-transplant assessments include lung function tests, walking tests, handgrip strength, and mobility tests. This study aims to compare the health-related physical fitness of individuals undergoing allogeneic hematopoietic stem cell transplantation with healthy controls.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 25, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 3, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

August 30, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2025

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2026

Completed
Last Updated

January 26, 2026

Status Verified

January 1, 2026

Enrollment Period

4 months

First QC Date

June 25, 2025

Last Update Submit

January 23, 2026

Conditions

Keywords

physical fitnessstem cell transplantation

Outcome Measures

Primary Outcomes (15)

  • Forced Expiratory Volume in One Second

    The volume of air that can be forcefully exhaled during the first second of a forced breath.

    4 weeks

  • Forced Vital Capacity

    The total volume of air that can be forcibly exhaled after taking the deepest breath possible.

    4 weeks

  • Forced Expiratory Volume in One Second to Forced Vital Capacity Ratio

    The percentage ratio of the volume of air exhaled in the first second to the total volume exhaled during the forced vital capacity test.

    4 weeks

  • Peak Expiratory Flow

    The maximum speed of expiration during a forced breath.

    4 weeks

  • Physical Activity Level:

    The level of physical activity will be assessed using the Turkish version of the short form of the International Physical Activity Questionnaire. This questionnaire was developed to measure health-related physical activity in populations and is both comprehensive and concise. It provides information on the time spent sitting, walking, and engaging in moderate and vigorous intensity physical activities. The total score is calculated by multiplying the duration and frequency of the physical activities reported. The energy expenditure associated with physical activities is expressed in metabolic equivalent-minute scores. Based on the scoring, the questionnaire categorizes individuals into three physical activity levels: inactive, moderately active, and active. The administration of the questionnaire can be conducted in two different formats: on paper or via a digital screen interface.

    4 weeks

  • Six-Minute Walk Test

    Functional exercise capacity will be evaluated using the Six-Minute Walk Test in accordance with the criteria of the American Thoracic Society and the European Respiratory Society. In this test, the individual is instructed to walk as fast as possible back and forth between two cones placed 30 meters apart in a straight corridor. Standardized encouragement phrases will be used throughout the test to motivate the participant. Vital signs will be assessed before and after the test, as well as during the recovery period. The total distance walked during the six-minute period will be recorded in meters, and the average walking speed will be calculated in meters per minute.

    4 weeks

  • Postural Assessment:

    The Posture Analysis Form developed by Corbin will be used for the assessment of postural alignment. The evaluation will be conducted through visual observation from both lateral and posterior views. The presence and severity of postural deviations will be assessed. Each item in the form is scored based on the severity of the deviation as follows: 0 = none, 1 = mild, 2 = moderate, 3 = severe. The total score will be used to classify the individual's overall postural status.

    4 weeks

  • Sit and Reach Test

    Sit and Reach Test reflects lower body flexibility. In this test, the patient will be seated in front of a box with dimensions of 35 cm length, 45 cm width, 32 cm height, and after leaning his bare feet on the inner surface of the box, patient will try to move the bar on the plate as far as patient can with both hands, the value at the last point will be recorded in cm.

    4 weeks

  • Assessment of Respiratory Muscle Strength

    Respiratory muscle strength will be evaluated by measuring maximum inspiratory mouth pressure and maximum expiratory mouth pressure using a portable electronic mouth pressure measurement device. Results will be recorded in cmH₂O. Maximum inspiratory mouth pressure is defined as the pressure generated in the mouth during maximal inspiration against an occluded airway. For this measurement, participants will first perform a maximal expiration, after which the airway will be closed with a valve, and the participant will be asked to perform a maximal inspiration sustained for 1-3 seconds. maximum expiratory mouth pressure refers to the pressure generated in the mouth during maximal expiration against a closed airway. For maximum expiratory mouth pressure measurement, after a maximal inspiration, the participant will be instructed to exhale maximally against the occluded airway for 1-3 seconds.

    4 weeks

  • Assessment of Peripheral Muscle Strength

    Peripheral muscle strength will be assessed for the following muscle groups: shoulder abductors, shoulder flexors, elbow flexors and extensors for the upper extremity; and hip flexors and knee extensors for the lower extremity. Measurements will be performed using a portable manual muscle strength testing device (Model 01165, Lafayette, Indiana, United States of America).

    4 weeks

  • Grip strength

    Grip strength will be assessed using a Jamar Hydraulic Hand Dynamometer (Jamar, Nottinghamshire, United Kingdom). Measurements will be performed in a seated position with the elbow flexed at 90 degrees and the wrist in a neutral position. Measurements for both right and left sides will be repeated three times, and the best value obtained will be recorded in kilograms.

    4 weeks

  • 30-Second Sit-to-Stand Test

    In this test, the participant is asked to sit down and stand up from a standard chair as many times as possible within 30 seconds, without using their arms. The number of full stands completed within the allotted time is recorded. This test provides functional information about lower extremity muscle strength.

    4 weeks

  • Flamingo Balance Test

    In this test, the participant is asked to stand barefoot in a flamingo-like position and maintain balance for as long as possible. The participant balances on one leg, while the other leg is flexed so that the foot touches the opposite knee. A stopwatch is started upon command. Each time balance is lost, the timer is paused, and restarted once balance is regained. The total number of balance losses within 1 minute is recorded. If the participant loses balance more than 15 times within the first 30 seconds, the test is terminated and scored as zero.

    4 weeks

  • Semmes-Weinstein Monofilament Test

    This test is performed to assess light touch and pressure sensations. The assessment tool consists of a series of monofilaments with varying thickness and diameters. These monofilaments apply graded forces ranging from 0.086 grams to 448 grams. The evaluation begins with the smallest monofilament and proceeds sequentially to thicker ones. The test is stopped, and the value is recorded, when the smallest monofilament perceived by the participant is identified. The monofilaments are applied from the first to the fifth finger, moving from distal to proximal regions, on both anterior and posterior surfaces of the hand.

    4 weeks

  • Quality of Life Assessment

    Quality of life, including physical and mental health components, will be assessed using the Short Form 36 Health Survey Questionnaire. The Short Form 36 is a 36-item self-report questionnaire that evaluates eight dimensions of health: physical functioning, role limitations due to physical health, role limitations due to emotional problems, social functioning, bodily pain, mental health, vitality, and general health perceptions. In addition to individual subscale scores, two summary scores-physical component summary and mental component summary-are calculated by combining the relevant subscales.

    4 weeks

Secondary Outcomes (5)

  • Height

    4 weeks

  • Weight

    4 weeks

  • Demographic data and physical characteristics

    4 weeks

  • Waist Circumference Measurement

    4 weeks

  • Hip Circumference Measurement:

    4 weeks

Study Arms (2)

Transplantation Group

Adult patients who underwent hematopoietic stem cell transplantation

Other: Assessment Group

Control Group

Healthy adults

Other: Control Group

Interventions

Adult healthy group with similar sociodemographic characteristics to the evaluation group.

Control Group

Allogeneic Stem Cell Transplant recipients will be evaluated with a supervisor physiotherapist for 2 days between the time they are admitted to the stem cell transplantation unit.

Transplantation Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

A total of 30 individuals will be included in the study, consisting of 15 adult patients who have undergone hematopoietic stem cell transplantation and meet the inclusion criteria from the Adult Bone Marrow Transplantation Unit, forming the research group, and 15 healthy individuals forming the control group. RPatients and healthy controls will be matched based on age and gender.The study will commence following Ethics Committee approval and will be conducted in accordance with the principles of the Declaration of Helsinki. Informed consent will be obtained from all participants included in the study.

You may qualify if:

  • Currently receiving treatment in the Adult Bone Marrow Transplantation Unit
  • Between 18 and 65 years of age
  • Undergoing standard medical treatment including immunosuppressants, antibiotics, and other medications
  • Clinically stable, able to walk, and cooperative
  • No history of orthopedic, neurological, or cardiac disorders

You may not qualify if:

  • Presence of cognitive impairments
  • Orthopedic or neurological diseases that may affect the evaluation of physical fitness tests
  • Presence of facial palsy
  • Severe visual impairment or visual field defects
  • Acute bleeding, hemoglobin level ≤ 8 g/dL, and platelet count ≤ 10,000/mm³

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istinye University

Istanbul, 34010, Turkey (Türkiye)

Location

MeSH Terms

Interventions

Control Groups

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asst. Prof.

Study Record Dates

First Submitted

June 25, 2025

First Posted

July 3, 2025

Study Start

August 30, 2025

Primary Completion

December 30, 2025

Study Completion

January 15, 2026

Last Updated

January 26, 2026

Record last verified: 2026-01

Locations